Author:
Ibrahim Muhammad Tukur,Uzairu Adamu,Shallangwa Gideon Adamu,Uba Sani
Reference40 articles.
1. Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1, 4-dihydroindeno [1, 2-c] pyrazole chalcone as EGFR/Akt pathway inhibitors;Khan;Eur. J. Med. Chem.,2019
2. Structural pharmacological studies on EGFR T790M/C797S;Kong;Biochem. Biophys. Res. Commun.,2017
3. Signatures of drug sensitivity in nonsmall cell lung cancer;Gong;Int. J. Proteom.,2011
4. Computer-aided molecular modeling studies of some 2, 3-dihydro-[1, 4] dioxino [2, 3-f] quinazoline derivatives as EGFR WT inhibitors Beni-Suef University;Ibrahim;J. Basic Appl. Sci.,2020
5. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer;Pao;Nat. Rev. Cancer,2010
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献